Lixte Biotechnology Holdings Inc (LIXT)
1.60
+0.08
(+5.26%)
USD |
NASDAQ |
Nov 22, 12:44
Lixte Biotechnology Holdings Net Income (Quarterly): -0.986M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.986M |
| June 30, 2024 | -1.011M |
| March 31, 2024 | -0.9713M |
| December 31, 2023 | -1.032M |
| September 30, 2023 | -1.019M |
| June 30, 2023 | -1.668M |
| March 31, 2023 | -1.368M |
| December 31, 2022 | -1.631M |
| September 30, 2022 | -1.478M |
| June 30, 2022 | -1.546M |
| March 31, 2022 | -1.657M |
| December 31, 2021 | -2.029M |
| September 30, 2021 | -1.239M |
| June 30, 2021 | -1.733M |
| March 31, 2021 | -1.727M |
| December 31, 2020 | -0.9069M |
| September 30, 2020 | -1.602M |
| June 30, 2020 | -0.3731M |
| March 31, 2020 | -0.3832M |
| December 31, 2019 | -0.3221M |
| September 30, 2019 | -1.079M |
| June 30, 2019 | -0.6105M |
| March 31, 2019 | -0.4287M |
| December 31, 2018 | -0.3486M |
| September 30, 2018 | -1.034M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.3714M |
| March 31, 2018 | -0.3792M |
| December 31, 2017 | -0.4326M |
| September 30, 2017 | -0.4624M |
| June 30, 2017 | -0.2928M |
| March 31, 2017 | -0.6206M |
| December 31, 2016 | -0.5163M |
| September 30, 2016 | -0.6469M |
| June 30, 2016 | -0.555M |
| March 31, 2016 | -0.4165M |
| December 31, 2015 | -0.6139M |
| September 30, 2015 | -0.7797M |
| June 30, 2015 | -0.5007M |
| March 31, 2015 | -0.9579M |
| December 31, 2014 | -0.5947M |
| September 30, 2014 | -0.5014M |
| June 30, 2014 | -0.7413M |
| March 31, 2014 | -0.9288M |
| December 31, 2013 | -0.359M |
| September 30, 2013 | -0.3131M |
| June 30, 2013 | -0.3688M |
| March 31, 2013 | -0.3339M |
| December 31, 2012 | -0.2757M |
| September 30, 2012 | -1.978M |
| June 30, 2012 | -0.734M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-2.029M
Minimum
Dec 2021
-0.3221M
Maximum
Dec 2019
-1.234M
Average
-1.303M
Median
Net Income (Quarterly) Benchmarks
| Shuttle Pharmaceuticals Holdings Inc | -3.784M |
| Soligenix Inc | -1.719M |
| Tonix Pharmaceuticals Holding Corp | -14.21M |
| NovaBay Pharmaceuticals Inc | -1.212M |
| Palatin Technologies Inc | -7.824M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.9833M |
| EPS Diluted (Quarterly) | -0.44 |
| Enterprise Value | 5.281M |
| Earnings Yield | -108.1% |